Biopsychosocial Determinants of Multi Drug Resistant Tuberculosis in Surakarta
Abstract
Background: Tuberculosis is an infectious disease that poses serious threat to population health worldwide. Tuberculosis control enterprise becomes more complicated due to increasing number of Multi Drug Resistant Tuberkulosis (MDR-TB) cases. Globally there are approximately 580,000 cases of MDR-TB, with only 125,000 cases (20%) resolved. Indonesia ranks tenth in the world by the number of MDR-TB cases after Angola, Azerbaijan, Bangladesh, Belarus, Cina, Korea, Kongo, Etiopia, and India. This study aimed to analyzed the bio-psychosocial determinants of MDR-TB in Surakarta.
Subjects and Method: This was an analytic observational study with case control design. The study was conducted in Dr. Moewardi Hospital and BBKPM, Surakarta, from September to November 2017. A sample consisting of 76 MDR-TB patients and 228 non MDR-TB patients were selected for this study by fixed disease sampling. The dependent variable was MDR-TB. The independent variables were age, drug-taking adherence, depression, comorbidity, drug side-effect, drug-taking supervisor, and family income. The data were collected using a set of questionnaire and analyzed by path analysis.
Results: MDR-TB was affected by lack of drug-taking adherence (b= -1.7; 95% CI= -2.23 to -1.07; p=0.001) and comorbidity (b= 1.5; 95% CI= 0.76 to 2.30; p=0.001). Drug-taking adherence was affected by depression (b= -1.7; 95% CI= -2.60 to -0.79; p=0.001), drug side effect (b= -1.5; CI 95%= -2.10 to -0.86; p=0.001), and drug-taking supervisor (b=2.5; 95% CI= 1.84 to 3.06; p=0.001). Comorbidity was affected by age (b= 0.86; 95% CI= 0.12 to 1.61; p= 0.022).
Conclusion: MDR-TB is directly affected by lack of drug-taking adherence and comorbidity. MDR-TB is indirectly affected by drug-taking supervisor, depression, and drug side effect.
Keyword: bio-psychosocial determinants, MDR-TB
Correspondence: Lina Alfiyani. Masters Program in Public Health, Sebelas Maret University, Jl. Ir. Sutami 36 A, Surakarta, Central Java. Email: linabbt@gmail.com.
Journal of Epidemiology and Public Health (2017), 2(3): 255-266
https://doi.org/10.26911/jepublichealth.2017.02.03.07
References
Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I et al. (2013). Tuberculosis 2013: 5 Drug resistant tuberculosis: Time For Visionary Political Leadership. Lancet Infect Dis. 13: 529–539.
Aderita NI, Murti B, Suryani N (2016). Risk Factors Affecting Multi Drug Resistant Tuberculosis in Surakarta and Wonogiri, Central Java, Indonesia. Journal of Health Promotion and Behavior, 1: 88–101.
Aibana O, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, Murray MB (2017). Risk Factors for Poor Multidrug Resistant Tuberculosis Treatment Outcomes in Kyiv. BMC Infectious Diseases, 17: 1–7.
Akshata JS, Chakrabarthy A (2016). Management of Multidrug Resistant Tuberculosis (MDR-TB) – Monitoring is the Key to Successful Outcome. Egyptian Journal of Chest Diseases and Tuberculosis, 65(2): 447–450.
Ambaw F, Mayston R, Hanlon C, Alem A (2015). Depression among Patients with Tuberculosis: Determinants, Course and Impact on Pathways to Care and Treatment Outcomes in a Primary Care Setting in Southern Ethiopia—a Study Protocol. BMJ Open, 5: 1–10.
Amita J, Pratima D (2008). Multidrug Resistant to Extensively Drug Resistant Tuberculosis: What is Next? (Special Issue. Emerging and Re Emerging Infections in India). Journal of Biosciences, 33: 605–616.
Atre S (2015). An Urgent Need for Building Technical Capacity for Rapid Diagnosis of Multidrug Resistant Tuberculosis (MDR-TB) Among New Cases: a Case Report from Maharashtra, India. Journal of Infection and Public Health, 8(5): 502–505.
Baghaei P, Tabarsi P, Moniri A, Marjani M, Velayati AA (2015). Impact of Diabetes Mellitus on Tuberculosis Drug Resistance in New Cases of Tuberculosis. International Journal of Mycobacteriology, 4: 128.
Bhunia SK., Sarkar M, Banerjee A, Giri B (2015). An Update on Pathogenesis and Management of Tuberculosis with Special Reference to Drug Resistance. Asian Pacific Journal of Tropical Disease, 5(9): 673–686.
Cuevas CD, Pe W (2015). Psychometric Properties of the EightItem Morisky Medication Adherence Scale (MMAS 8) in a Psychiatric Nate. International Journal of Clinical and Health Psychology, 15: 121-129.
Dinas Kesehatan Provinsi Jawa Tengah (2016). Buku Saku Kesehatan Triwulan 2 tahun 2016. Semarang: Dinas Kesehatan Provinsi Jawa Tengah.
Duko B, Gebeyehu A, Ayano G (2015). Prevalence and Correlates of Depression and Anxiety Among Patients with Tuberculosis at Wolaitasodo University Hospital and Sodo Health Center, Wolaitasodo, South Ethiopia, Cross.BMC Psychiatry, 1–7.
Fagundez G, Freixo HP, Eyene J, Carlos Momo J, Biye L, Esono T, Marcial OM et al. (2016). Treatment Adherence of Tuberculosis Patients Attending Two Reference Units in Equatorial Guinea. PLoS ONE, 11 (9): e0161995.
Falzon D, Jaramillo E, Wares F, Zignol M, Floyd K, Raviglione MC (2013). Universal Access to Care for Multidrug Resistant Tuberculosis: an Analysis of Surveillance Data.The Lancet Infectious Diseases, 13(8): 690–697.
Farazi A, Sofian M, Jabbariasl M, Keshavarz S (2014). Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients. Tuberculosis Research and Treatment, 1–6.
Gao J , Ma Y, Du J, Zhu G, Tan S, Fu Y, Ma L et al. (2016). Later Emergence of Acquired Drug Resistance and its Effect on Treatment Outcome in Patients Treated with Standard Short Course Chemotherapy for Tuberculosis. BMC Pulmonary Medicine, 16:26.
He T (2016). Social Support Received by Multidrug Resistant Tuberculosis Patients and Related Factors : a Cross Sectional Study in Zhejiang Province, People’s Republic of China. Patient Preference and Adherence, 10: 1063–1070.
Hirpa S, Medhin G, Girma B, Melese M, Mekonen A, Suarez P (2013). Determinants of Multidrug Resistant Tuberculosis in Patients Who Underwent First Line Treatment in Addis Ababa: a Case Control Study. BMC Public Health, 13(1): 1.
Kemenkes RI (2014). Strategi Nasional Pengendalian TB. Jakarta: Kemenkes RI.
_____ (2015). Buku Petunjuk Teknis Penemuan Pasien TB DM di Fasilitas Kesehatan Rujukan. Jakarta: Kemenkes RI.
_____ (2016). InfoDatin 2016 TB. Jakarta: Kemenkes RI.
Koyanagi A, Vancampfort D, Carvalho AF, DeVylder JE, Haro JM, Pizzo D, Veronese N et al. (2017). Depression Comorbid with Tuberculosis and its Impact on Health Status: Cross Sectional Analysis of Community Based Data From 48 Low and Middle Income Countries. BMC Medicine, 15(1): 1–10.
Liu YX, Pang CK, Liu Y, Sun X, Bin, Li XX, Jiang S et al. (2015). Association Multidrug Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling. PLoS ONE, 10(5): 1–14.
Magee MJ, Bloss E, Shin SS, Contreras C, Huamane HA, Ticona JC, Bayona J et al. (2013). International Journal of Infectious Diseases Clinical Characteristics, Drug Resistance, and Treatment Outcomes among Tuberculosis Patients with Diabetes in Peru. International Journal of Infectious Diseases, 17(6): 404–e412.
Mekonnen F, Tessema B , Moges F, Gelaw A, Eshetie S, Kumera G (2015). Multidrug Resistant Tuberculosis: Prevalence and Risk Factors in Districts of Metema and West Armachiho, Northwest Ethiopia. BMC Infectious Diseases, 2–7.
Mohd N, Azhar S, Kamaludin F (2015). The Risk Factors of Multidrug Resistant Tuberculosis among Malaysians. International Journal of Mycobacteriology, 5(1): 51–58.
Navarro LM, Fuentes FJ, Zenteno CR (2015). Type 2 Diabetes Mellitus and its Influence in the Development of Multidrug Resistance Tuberculosis in Patients From Southeastern Mexico. Journal of Diabetes and its Complications, 29(1): 77–82.
Pachi A, Bratis D, Moussas G, Tselebis A (2013). Psychiatric Morbidity and Other Factors Affecting Treatment Adherence in Pulmonary Tuberculosis Patients. Tuberculosis Research and Treatment.
Peddireddy V (2016). Quality of Life, Psychological Interventions and Treatment Outcome in Tuberculosis Patients: the Indian Scenario Psychological Distress in Tuberculosis. Frontiers in Psichology, 1–9.
Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, Barcellini L et al. (2016).Characterization of The CD4 and CD8 T Cell Responses to Quantiferon TB Plus. Journal of Infection, 73(6): 588–597.
Prosser G, Brandenburg J, Reiling N, Barry CE, Wilkinson RJ, Wilkinson KA (2016). The Bacillary and Macrophage Response to Hypoxia in Tuberculosis and the Consequences for T Cell Antigen Recognition., Microbes and infection, 1–16.
Septia A, Rahmalia S, Sabrian F (2013). Hubungan Dukungan Keluarga dengan Kepatuhan Minum Obat pada Penderita TB Paru. JOM Psikology, 1–10.
Sulistiyani, Wahjono H, Sabdono A, Khoeri MM, Karyana E (2015). Antimycobacterial Activities from Seagrass Enhalus sp. Associated Bacteria Against Multi Drug Resistance Tuberculosis (MDR TB) Bacteria. Procedia Environmental Sciences, 23:253–259.
Tao N, He X, Zhang X, Liu Y, Yu C, Li H (2017). International Journal of Infectious Diseases Trends and Characteristics of Drug Resistant Tuberculosis in Rural. International Journal of Infectious Diseases, 65: 8–14.
Theron G,Peter J, Zijenah L, Chanda D, Mangu C, Clowes P, Rachow A et al. (2015). Psychological Distress and its Relationship with Non Adherence to TB Treatment: a Multicentre Study. BMC Infectious Diseases,13-19.
Thi TH, Nguyen NV, Dinh SN, Nguyen HB, Cobelens F, Thwaites G, Nguyen HT et al. (2015). Challenges in Detection and Treatment of Multidrug Resistant Tuberculosis Patients in Vietnam. BMC Public Health, 1–10.
Thomas BE, Shanmugam P, Malaisamy M, Ovung S, Suresh C, Subbaraman R, Adinarayanan S (2016). Psycho Socio Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: a Systematic Review. PLoS ONE, 1–15.
Vijay S, Kumar P, Chauhan LS, Hanum anthappa B, Kizhakkethil UP, Rao SG (2010). Risk Factors Associated with Default among New Smear Positive TB Patients Treated Under DOTS in India. Tuberculosis Research and Treatment, 5(4).
Viswanathan V, Vigneswari A, Selvan K, Satyavani K, Rajeswari R, Kapur A (2014). Journal of Diabetes and its Complications Effect of Diabetes on Treatment Outcome of Smear Positive Pulmonary tuberculosis A report from South India. Journal of Diabetes and Its Complications, 28(2): 162–165.
Wahyuni M, Amir Z, Yunita R, Rahardjo W, Abidin A, Malik AR (2016). Pengaruh Merokok Terhadap Konversi Sputum pada Penderita Tuberkulosis Paru Kategori I. J Respir Indo, 36(2): 106–112.
WHO (2016a). Global Report Tuberculosis Report 2016. Geneva: WHO Press.
_____ (2016b). World Health Statistics SDG s. Geneva: WHO Press.
_____ (2017). Global Tuberculosis Report 2017. Geneva: WHO Press.
Woimo TT, Yimer WK, Bati T, Gesesew HA (2017). The Prevalence and Factors Associated for Anti Tuberculosis Treatment Non Adherence among Pulmonary Tuberculosis Patients in Public Health Care Facilities in South Ethiopia: a Cross Sectional Study. BMC Public Health, 17(1): 269.
Young F, Critchley JA, Johnstone LK, Unwin NC (2009). Globalization And Health aReview of Co Morbidity Between Infectious and Chronic Disease in Sub Saharan Africa : TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the Impact of Globalization. BMC Public Health, 9: 1–9.
Zhang C, Wang Y, Shi G, Han W, Zhao H, Zhang H (2016). Determinants of MultidrugResistant Tuberculosis in Henan Province China: a Case Control Study. BMC Public Health, 1–8.
